Role of Extracellular MicroRNAs in Myocardial Ischemia-Reperfusion Injury

细胞外微小RNA在心肌缺血再灌注损伤中的作用

基本信息

  • 批准号:
    9175739
  • 负责人:
  • 金额:
    $ 47.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-01 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary Heart diseases including ischemic myocardial infarction (MI) continue to be the leading cause of mortality in the U.S. While reperfusion therapy such as percutaneous coronary intervention remains the most effective strategy to limit infarct size and preserve cardiac function, reperfusion itself can cause lethal injury to myocardium. In response to ischemia-reperfusion (I/R), myocardium releases various danger molecules that are proven to be harmful to the heart. We have recently identified that cellular RNAs including many microRNAs (miRNAs) are released from the heart during I/R and that extracellular RNA contributes to myocardial inflammation and injury. Our preliminary investigations demonstrate that RNA isolated from the heart or single-stranded miRNA mimics (miR-34, -122, -133a, -142, 146a, -208a) induce a robust cytokine response in cardiomyocytes, neutrophils, and macrophages. Using genetic deletion models and pharmacological inhibitors, we demonstrate, in cell-based assays, that cardiac RNAs or microRNA mimics induce cytokine production specifically through the innate immune Toll-like receptor 7 (TLR7) signaling. The over goals of this proposal are to determine the role of extracellular miRNAs in myocardial I/R injury and explore the underlying molecular mechanisms. The proposal is based on the following three hypotheses: 1) that miRNAs are released from injured myocardium during I/R and play a role in myocardial inflammation and injury, 2) that miRNAs act through TLR7 signaling in cardiomyocytes and neutrophils, 3) that pharmacological inhibition of miRNAs and TLR7 signaling after ischemic insult will offer cardio-protection against I/R injury. In Specific Aim 1, we will determine the contribution of extracellular miRNAs to myocardial inflammation and injury during I/R. In Specific Aim 2, we will test the role of TLR7 signaling in miRNA-mediated myocardial inflammation and injury in I/R. In Specific Aim 3, we will explore the miRNA-TLR7 signaling as a potential therapeutic target for the treatment of myocardial I/R injury. The proposed studies address a unique and novel function of extracellular miRNAs in myocardial inflammation and injury, with significant implications in pathogenesis and treatment of ischemic myocardial infarction.
项目摘要 包括缺血性心肌梗死(MI)在内的心脏病仍然是20世纪90年代死亡的主要原因。 美国而再灌注治疗如经皮冠状动脉介入治疗仍然是最有效的策略 为了限制梗死面积和保护心脏功能,再灌注本身可对心肌造成致命损伤。在 心肌对缺血再灌注(I/R)的反应是释放各种危险分子,这些分子被证明是 对心脏有害。我们最近发现,细胞RNA,包括许多microRNA(miRNAs), 在I/R期间从心脏释放细胞外RNA,并且细胞外RNA有助于心肌炎症和损伤。 我们的初步研究表明,从心脏中分离的RNA或单链miRNA模拟物 (miR-34,-122,-133a,-142,146 a,-208a)在心肌细胞、嗜中性粒细胞和巨噬细胞中诱导稳健的细胞因子应答。 巨噬细胞使用遗传缺失模型和药理学抑制剂,我们证明,在基于细胞的 实验表明,心脏RNA或microRNA模拟物特异性地通过先天性巨噬细胞诱导细胞因子产生。 免疫Toll样受体7(TLR 7)信号传导。该提案的总体目标是确定 本研究旨在探讨细胞外miRNAs在心肌I/R损伤中的作用及其分子机制。 该建议基于以下三个假设:1)miRNAs从损伤的心肌中释放 在I/R过程中发挥作用,并在心肌炎症和损伤中发挥作用,2)miRNA通过TLR 7信号传导发挥作用 在心肌细胞和嗜中性粒细胞中,3)在心肌细胞和嗜中性粒细胞中, 缺血性损伤将提供针对I/R损伤心脏保护。在具体目标1中,我们将确定 细胞外miRNAs在I/R期间心肌炎症和损伤中的作用在Aim Specific 2中,我们 将测试TLR 7信号传导在I/R中miRNA介导的心肌炎症和损伤中的作用。在特定 目的3,我们将探索miRNA-TLR 7信号通路作为治疗糖尿病的潜在治疗靶点。 心肌I/R损伤。这些研究提出了细胞外miRNAs的一种独特的新功能, 心肌炎症和损伤,在缺血性心脏病的发病机制和治疗中具有重要意义。 心肌梗死

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEI CHAO其他文献

WEI CHAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEI CHAO', 18)}}的其他基金

Extracellular miRNAs, innate immunity, and critical illness
细胞外 miRNA、先天免疫和危重疾病
  • 批准号:
    10164444
  • 财政年份:
    2021
  • 资助金额:
    $ 47.81万
  • 项目类别:
Extracellular miRNAs, innate immunity, and critical illness
细胞外 miRNA、先天免疫和危重疾病
  • 批准号:
    10578765
  • 财政年份:
    2021
  • 资助金额:
    $ 47.81万
  • 项目类别:
Extracellular miRNAs, innate immunity, and critical illness
细胞外 miRNA、先天免疫和危重疾病
  • 批准号:
    10400093
  • 财政年份:
    2021
  • 资助金额:
    $ 47.81万
  • 项目类别:
Extracellular miRNAs, innate immunity, and critical illness
细胞外 miRNA、先天免疫和危重疾病
  • 批准号:
    10795223
  • 财政年份:
    2021
  • 资助金额:
    $ 47.81万
  • 项目类别:
Targeting brain inflammation and neurocognitive dysfunction in sepsis
针对脓毒症中的脑部炎症和神经认知功能障碍
  • 批准号:
    9917852
  • 财政年份:
    2019
  • 资助金额:
    $ 47.81万
  • 项目类别:
Targeting brain inflammation and neurocognitive dysfunction in sepsis
针对脓毒症中的脑部炎症和神经认知功能障碍
  • 批准号:
    10093156
  • 财政年份:
    2019
  • 资助金额:
    $ 47.81万
  • 项目类别:
Targeting brain inflammation and neurocognitive dysfunction in sepsis
针对脓毒症中的脑部炎症和神经认知功能障碍
  • 批准号:
    10350552
  • 财政年份:
    2019
  • 资助金额:
    $ 47.81万
  • 项目类别:
Role of Extracellular MicroRNAs in Myocardial Ischemia-Reperfusion Injury
细胞外微小RNA在心肌缺血再灌注损伤中的作用
  • 批准号:
    9321058
  • 财政年份:
    2016
  • 资助金额:
    $ 47.81万
  • 项目类别:
Role of TLR-cfB Signaling in Sepsis
TLR-cfB 信号传导在脓毒症中的作用
  • 批准号:
    8238543
  • 财政年份:
    2012
  • 资助金额:
    $ 47.81万
  • 项目类别:
Role of TLR-cfB Signaling in Sepsis
TLR-cfB 信号传导在脓毒症中的作用
  • 批准号:
    8676814
  • 财政年份:
    2012
  • 资助金额:
    $ 47.81万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.81万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了